About WhatsNU genomics
WhatsNU genomics is a company based in Singapore (Singapore) founded in 2019. It operates as a B2B and SaaS. WhatsNU genomics offers products and services including KayalOME Technology and Precision Medicine Services. WhatsNU genomics operates in a competitive market with competitors including Denali Therapeutics, Castle Biosciences, Juno Therapeutics, Unity Biotechnology and Unilabs, among others.
- Headquarter Singapore, Singapore
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kriya Mediaworks Pvt Ltd
- Jurisdiction Kurnool, Andhra Pradesh, India
-
Annual Revenue
$5.52 K (USD)267.36as on Mar 31, 2017
-
Net Profit
-$109.96 (USD)79.7as on Mar 31, 2017
-
EBITDA
$46.59 (USD)112.1as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of WhatsNU genomics
WhatsNU genomics offers a comprehensive portfolio of products and services, including KayalOME Technology and Precision Medicine Services.
AI tool for predicting causal genes in inherited genetic disorders.
Services for AI-driven genomic analysis and clinical diagnostics.
Funding Insights of WhatsNU genomics
Detailed funding history for WhatsNU genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by WhatsNU genomics
Investment portfolio details for WhatsNU genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - WhatsNU genomics
Detailed financials for WhatsNU genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Whatsnu Genomics Comparisons
Peer comparison for WhatsNU genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of WhatsNU genomics
WhatsNU genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Castle Biosciences, Juno Therapeutics, Unity Biotechnology and Unilabs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| Locked | Locked | Locked |
Diagnostic services are provided through laboratories and radiology units.
|
|
| Locked | Locked | Locked |
Single-cell RNA and genomic analysis for precision therapeutics are provided.
|
Detailed competitors of WhatsNU genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Whatsnu Genomics
Complete news archive for WhatsNU genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WhatsNU genomics
WhatsNU genomics was founded in 2019.
WhatsNU genomics is headquartered in Singapore, Singapore.
Annual revenue of WhatsNU genomics is $5.52K as on Mar 31, 2017.
WhatsNU Genomics focuses on researching and developing AI-based tools for clinical diagnosis of inherited retinal disorders and other genetic conditions. They offer products like KayalOME Technology, an AI screening tool for predicting causal genes. The company operates in Singapore, providing services in precision medicine diagnostics and therapeutics. Their activities include bioinformatics, human genetics, and deep learning applications, targeting medical and research institutions.
WhatsNU genomics's top competitors include Juno Therapeutics, Ambrx and Denali Therapeutics.
WhatsNU genomics offers KayalOME Technology and Precision Medicine Services.